BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11395307)

  • 1. Characterization of r-[11C]rolipram for PET imaging of phosphodieterase-4: in vivo binding, metabolism, and dosimetry studies in rats.
    Lourenco CM; Houle S; Wilson AA; DaSilva JN
    Nucl Med Biol; 2001 May; 28(4):347-58. PubMed ID: 11395307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
    Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
    Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4.
    Parker CA; Matthews JC; Gunn RN; Martarello L; Cunningham VJ; Dommett D; Knibb ST; Bender D; Jakobsen S; Brown J; Gee AD
    Synapse; 2005 Mar; 55(4):270-9. PubMed ID: 15668983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues.
    Kenk M; Greene M; Lortie M; Dekemp RA; Beanlands RS; Dasilva JN
    Nucl Med Biol; 2008 May; 35(4):515-21. PubMed ID: 18482689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography.
    DaSilva JN; Lourenco CM; Meyer JH; Hussey D; Potter WZ; Houle S
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1680-3. PubMed ID: 12458404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]Rolipram-PET.
    Fujita M; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Lu JQ; Liow JS; Seneca N; Tipre DN; Cropley VL; Imaizumi M; Gee AD; Seidel J; Green MV; Pike VW; Innis RB
    Neuroimage; 2005 Jul; 26(4):1201-10. PubMed ID: 15961054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of cAMP-specific phosphodiesterase-IV: comparison of [11C]rolipram and [11C]Ro 20-1724 in rats.
    Lourenco CM; DaSilva JN; Warsh JJ; Wilson AA; Houle S
    Synapse; 1999 Jan; 31(1):41-50. PubMed ID: 10025682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart.
    Thomas AJ; DaSilva JN; Lortie M; Renaud JM; Kenk M; Beanlands RS; deKemp RA
    J Nucl Med; 2011 Feb; 52(2):263-9. PubMed ID: 21270457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration.
    Fujita M; Imaizumi M; D'Sa C; Zoghbi SS; Crescenzo MS; Hong J; Musachio JL; Gee AD; Seidel J; Green MV; Pike VW; Duman RS; Innis RB
    Synapse; 2007 Feb; 61(2):78-86. PubMed ID: 17117418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET measurement of the in vivo affinity of 11C-(R)-rolipram and the density of its target, phosphodiesterase-4, in the brains of conscious and anesthetized rats.
    Itoh T; Abe K; Zoghbi SS; Inoue O; Hong J; Imaizumi M; Pike VW; Innis RB; Fujita M
    J Nucl Med; 2009 May; 50(5):749-56. PubMed ID: 19372471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart.
    Lourenco CM; Kenk M; Beanlands RS; DaSilva JN
    Life Sci; 2006 Jun; 79(4):356-64. PubMed ID: 16499932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram.
    Zhao Y; Zhang HT; O'Donnell JM
    J Pharmacol Exp Ther; 2003 May; 305(2):565-72. PubMed ID: 12704225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
    Makhay MM; Houslay MD; O'Donnell JM
    Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the cofactor-dependent and independent bindings of PDE4 inhibitors.
    Liu S; Laliberté F; Bobechko B; Bartlett A; Lario P; Gorseth E; Van Hamme J; Gresser MJ; Huang Z
    Biochemistry; 2001 Aug; 40(34):10179-86. PubMed ID: 11513595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.
    Michie AM; Lobban M; Müller T; Harnett MM; Houslay MD
    Cell Signal; 1996 Feb; 8(2):97-110. PubMed ID: 8730511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
    Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
    Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
    Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):425-36. PubMed ID: 8809029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex.
    Ye Y; O'Donnell JM
    J Neurochem; 1996 May; 66(5):1894-902. PubMed ID: 8780016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.